Differences in surface expression of NspA among Neisseria meningitidis group B strains.
about
Prospects for vaccine prevention of meningococcal infectionNadA, a novel vaccine candidate of Neisseria meningitidisThe meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complementFur-mediated activation of gene transcription in the human pathogen Neisseria gonorrhoeae.Characterization of MspA, an immunogenic autotransporter protein that mediates adhesion to epithelial and endothelial cells in Neisseria meningitidis.Conformational epitopes recognized by protective anti-neisserial surface protein A antibodies.Epitopes recognized by a nonautoreactive murine anti-N-propionyl meningococcal group B polysaccharide monoclonal antibody.Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo.Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat modelReview of meningococcal group B vaccines.The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies.Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.Effect of human serum on de-N-acetyl sialic acid epitope expression and antibody activity against N. meningitidis group BSequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains.Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitidis Lip/H.8 and Laz lipoproteinsIdentification of iron-activated and -repressed Fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B.Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in miceThe discovery and development of a novel vaccine to protect against Neisseria meningitidis Serogroup B Disease.Contribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumannii.The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococciFunctional and specific antibody responses in adult volunteers in new zealand who were given one of two different meningococcal serogroup B outer membrane vesicle vaccines.A universal vaccine for serogroup B meningococcusAdditive and synergistic bactericidal activity of antibodies directed against minor outer membrane proteins of Neisseria meningitidis.Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccineImpaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice.Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine.Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.Vaccine potential of the Neisseria meningitidis 2086 lipoprotein.Immunization with Outer Membrane Vesicles Displaying Designer Glycotopes Yields Class-Switched, Glycan-Specific Antibodies.Naturally acquired passive protective activity against Neisseria meningitidis Group C in the absence of serum bactericidal activity.Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.A naturally occurring single-residue mutation in the translocator domain of Neisseria meningitidis NhhA affects trimerization, surface localization, and adhesive capabilities.Working mechanism of immunoglobulin A1 (IgA1) protease: cleavage of IgA1 antibody to Neisseria meningitidis PorA requires de novo synthesis of IgA1 Protease.
P2860
Q24537338-4F52261A-E6F6-4A02-828D-4115738E68CDQ24675323-32AD5E3F-B5CC-4BCE-9F90-902DF88F1418Q28474974-CB2FAE98-18E5-449D-8FCC-740BD6F8AC6FQ29346563-D196D293-D7CD-4E95-B0EB-FD41D6442155Q30159832-AB8CD6EA-48A2-45EB-90CB-3E6C6096A3F8Q30164390-E8DE0B4F-E6E7-4884-986A-A1B0C8BA56B1Q31155603-367EBA8A-B115-4340-9B70-B5485398C540Q33184132-DE18DBBF-E3B3-4E1C-BC62-C809E61494D4Q33602953-C3C8FA25-57D1-4582-8CC8-073C1097C32DQ33646965-EC3F57F2-D208-4D9F-9BC3-9F1A1A81433EQ33792844-9EA43D7B-EED1-4BE4-B418-9AA6E3ABCBF6Q34007332-9AE96FBF-BF21-4BF9-8394-E4A4EF4568DFQ34007747-EDB228E3-3F7A-4CC9-A3A4-2A5A864E0D09Q34076321-C79CA386-1794-4EAF-BDC6-73EB5FF966FAQ34185172-E0F74998-4781-4CD8-B517-567A046FA863Q35075181-CC05469C-E516-43A9-9955-A6EEAFA96CB8Q35234880-126FD45E-8491-4B30-B6AA-C31B60AAAC5DQ35530224-37FFA905-F74F-42E9-BC93-AFB65B4608F5Q35886792-723ACC05-7F0C-4578-9E2D-30EC765CF5A9Q35895209-04A9C988-2515-4667-9313-2B5374857A4FQ35936064-37B840B7-E434-4902-9CDF-817EA462FCE9Q35946901-4AD3EAED-345C-4DC9-86D3-9B26464087DCQ36101910-D10AEE90-F381-4FC7-BBE8-E83D6E49CA17Q36313869-40D2BA04-A5D9-41D3-A7DB-F474A85229D6Q36464572-F308DFEB-9659-49BE-B654-4AE7151FD449Q36513433-6602A70B-97F4-43C7-A79C-7B7095EC210DQ36558734-CFDEEACA-1475-4740-BC17-465632DA03EBQ36638451-D49FF175-F6E0-422B-B500-0F8E7F545848Q36710765-C725E586-F759-47DA-B06D-3BED58529375Q37115883-75AFF03F-8152-4A71-8675-787E8573E417Q37425396-4CFE0D6C-0826-44C9-8B5D-409DEB2F28F0Q37523580-BB722684-8F14-41D4-AD5E-528076D0C2DFQ37582852-DDDC3325-4B3D-451A-88C5-FBBFD844FDA1Q38606992-E9C4CAEA-4426-4A7C-B291-859CEF37C37FQ39489794-0E54A4B4-4AD5-42BA-AC16-03775D5F6566Q41971192-A4B63DD2-6064-4147-A70E-41C15BCBC80B
P2860
Differences in surface expression of NspA among Neisseria meningitidis group B strains.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Differences in surface expression of NspA among Neisseria meningitidis group B strains.
@ast
Differences in surface expression of NspA among Neisseria meningitidis group B strains.
@en
Differences in surface expression of NspA among Neisseria meningitidis group B strains.
@nl
type
label
Differences in surface expression of NspA among Neisseria meningitidis group B strains.
@ast
Differences in surface expression of NspA among Neisseria meningitidis group B strains.
@en
Differences in surface expression of NspA among Neisseria meningitidis group B strains.
@nl
prefLabel
Differences in surface expression of NspA among Neisseria meningitidis group B strains.
@ast
Differences in surface expression of NspA among Neisseria meningitidis group B strains.
@en
Differences in surface expression of NspA among Neisseria meningitidis group B strains.
@nl
P2093
P2860
P1476
Differences in surface expression of NspA among Neisseria meningitidis group B strains
@en
P2093
P2860
P304
P407
P577
1999-11-01T00:00:00Z